<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

7 min read

SmartTRAK Highlights Recent Studies in OrthoBio

2/27/20 9:30 AM

Clinical Trial UpdatesHere are some highlights of recently announced trials in OrthoBio that were picked up by our analysts, posted on SmartTRAK, and included in our Daily Updates email.

A 76-pt study is underway evaluating if pts who receive a bioinductive graft (REGENETEN) have better function and fewer re-tear at 1-yr post-op vs those who received a debridement alone. Anticipated completion date is 9/23. clinicaltrials.gov

A 30-pt double blind, randomized, split mouth study was initiated evaluating the non-inferiority of Fibro-Gide in comparison to connective tissue graft for the tx of Miller Class I or II recession defects at 6 mos post tx. clinicaltrials.gov

Find out more about SmartTRAK Daily Updates and Request a Demo

ROSM and EmCyte have initiated an 84-pt study assessing if LP-PRP (PurePRP) to both the IA space and EA supporting capsular ligament and tendon structures provides a significant clinical benefit vs IA tx alone for hip OA. Expected completion date is 12/1/21. clinicaltrials.gov

Investigators have completed an 81-pt study evaluating NOVOCART 3D in adult and adolescent pts w/ full-thickness cartilage defects of the knee. No study results posted. clinicaltrials.gov

BONESUPPORT is initiating a 300-pt registry to compile data on the performance of CERAMENT BVF in normal orthopedic use. Estimated completion date is 2/1/22. clinicaltrials.gov

All SmartTRAK subscribers receive Daily or Weekly Update emails containing content curated by our analysts, all former marketing, R&D or competitive intelligence professionals with leading medical device companies. The updates contain the latest need-to-know news from earnings calls, conferences, studies, patent filings, new products and more. It's the perfect way to start your day!

Request a Demo of the SmartTRAK
Business Intelligence Portal!

Topics: Orthobiologics

Lindsey Wolejko
Written by Lindsey Wolejko

Senior Director Commerical Marketing. 12+ years experience in marketing and branding with a strong focus on healthcare and finance. Roles in Account Management and Brand Strategy with the likes of Ogilvy and Connecticut's top shop, Cronin. MBA in consulting from the University of Connecticut's School of Business.

    Recent Articles